Showing results (31-40 of 184) with videos related to

Sort By:
Pageof 19
Journal of the American College of Cardiology|September 1, 1993
Influence of heparin and systemic lysis on coronary blood flow after reperfusion induced by the novel recombinant plasminogen activator BM 06.022 in a canine model of coronary thrombosisU Martin, S Fischer, G Sponer
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 1, 1993
Differential fibrinolytic properties of the recombinant plasminogen activator BM 06.022 in human plasma and blood clot systems in vitroU Martin, G Sponer, K Strein
International Journal of Hematology|October 1, 1992
Hirudin and sulotroban improve coronary blood flow after reperfusion induced by the novel recombinant plasminogen activator BM 06.022 in a canine model of coronary artery thrombosisU Martin, G Sponer, K Strein
Journal of Cardiovascular Pharmacology|March 1, 1993
Rapid reversal of canine thromboembolic pulmonary hypertension by bolus injection of the novel recombinant plasminogen activator BM 06.022U Martin, G Sponer, K Strein
Nature Immunology|January 20, 2016
Interleukin 33 is a guardian of barriers and a local alarminNikolas T Martin, Michael U Martin
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1993
Influence of hepatic and renal failure on pharmacokinetic properties of the novel recombinant plasminogen activator BM 06.022 in ratsU Martin, G Sponer, K Strein
British Journal of Pharmacology|May 1, 1996
Comparison of desulfatohirudin (REVASC) and heparin as adjuncts to thrombolytic therapy with reteplase in a canine model of coronary thrombosisU Martin, L Dörge, S Fischer
Dysphagia|January 1, 1992
Meeting the oral health needs of institutionalized elderlyK U Martin, J O Martin
International Archives of Allergy and Applied Immunology|January 1, 1982
Phagocytosis of mast cell granules by mononuclear phagocytes, neutrophils and eosinophils during anaphylaxisM Baggiolini, U Horisberger, U Martin
Clinical Pharmacokinetics|May 13, 1999
Current clinical use of reteplase for thrombolysis. A pharmacokinetic-pharmacodynamic perspectiveU Martin, B Kaufmann, G Neugebauer
Pageof 19